The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials (Q35059066)

6 August 2017

1 reference

title

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials (English)

1 reference

6 August 2017

1 reference

A Bottomley

1

1 reference

6 August 2017

V Vanvoorden

2

1 reference

6 August 2017

H Flechtner

3

1 reference

6 August 2017

P Therasse

4

1 reference

6 August 2017

EORTC Quality of Life Group EORTC Data Center

5

1 reference

6 August 2017

publication date

1 February 2003

1 reference

European Journal of Cancer

6 August 2017

published in

1 reference

6 August 2017

volume

39

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

275-285

1 reference

Compliance issues in quality of life assessment: experiences of two Cancer Research Campaign sponsored groups.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Missing quality of life data in cancer clinical trials: serious problems and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Lessons learned from measuring health-related quality of life in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Quality of life instruments in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Use of quality-of-life outcome assessments in current cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

The development and utilisation of the European Organisation for research and treatment of cancer quality of life group item bank.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Science, language, intuition, and the many meanings of quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative G

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

The standard of reporting of health-related quality of life in clinical cancer trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Reporting on quality of life in randomised controlled trials: bibliographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Collecting quality of life data in EORTC clinical trials--what happens in practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Incomplete quality of life data in randomized trials: missing forms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Why are missing quality of life data a problem in clinical trials of cancer therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Do quality of life assessments make a difference in the evaluation of cancer treatments?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Completion rates in health-related quality-of-life assessment: approach of the National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

Standards are needed for quality of life clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900729-3

7 January 2021

10.1016/S0959-8049(02)00729-3

Identifiers

DOI

1 reference

6 August 2017

1 reference